Influence of vanadate on glycolysis, intracellular sodium, and pH in perfused rat hearts

Molecular and Cellular Biochemistry

Volumn 170, Issue 1-2, 1997, Pages 53-64

  Geraldes, Carlos F G C ^a   Castro, M Margarida C A ^a   Sherry, A Dean ^b,c   Ramasamy, Ravichandran ^d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glycolysis; Intracellular sodium; Ischemia reperfusion; NMR; Perfused rat hearts; Vanadate effects

Indexed keywords

3 HYDROXYBUTYRIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; GLUCOSE; LACTIC ACID; PALMITIC ACID; SODIUM; SODIUM 23; VANADIC ACID;

ACIDOSIS; ANIMAL TISSUE; ARTICLE; ASSAY; CELL PH; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOLYSIS; HEART MUSCLE; HEART MUSCLE REPERFUSION; HEART PERFUSION; HIGH ENERGY PHOSPHATE; ISCHEMIA; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; RAT; SODIUM CELL LEVEL; SODIUM TRANSPORT; TISSUE LEVEL;

EID: 8244241759     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006899932108     Document Type: Article

References (58)

1. Brichard A, Henquin JC: The role of vanadium in the management of diabetes. TiPS 16: 265-270, 1995
2. Ramasarma T, Crane FL: Does vanadium play a role in cellular regulation? Curr Top Cell Reg 20: 247-301, 1981
3. Nechay BR: Mechanisms of action of vanadium. Ann Rev Pharmacol Toxicol 24: 501-524, 1984
4. Hopkins LL, Mohr HE: Vanadium is an essential nutrient. Fed Proc 33: 1773-1775, 1974
5. Macara IG: Vanadium - an element in search of a role: Trends in Biochem Sci 5: 9294, 1980
6. Cantley LC Jr, Josephson L, Warner R, Yanagisawa M, Lechene C, Guidotti G: Vanadate is a potent (Na, K)-ATPase inhibitor found in ATP derived from muscle. J Biol Chem 252: 7421-7423, 1977
7. Cantley LC Jr, Aisen P: The fate of cytoplasmic vanadium. J Biol Chem 254: 1781-1784, 1979
8. Schechter Y: Insulin mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes 39: 1-5, 1990
9. Tolman EL, Barris E, Burns M, Pansini A, Pateridge R: Effects of vanadium on glucose metabolism in vitro. Life Sci 25: 1159-1164, 1979
10. Dubyak GR, Kleinzeller A: The insulin-mimetic effect of vanadate in isolated rat adipocytes. J Biol Chem 255: 5306-5312, 1980
11. Schechter Y, Karlish SJD: Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl(IV) ions. Nature 284: 556-558, 1980
12. 45Ca-efflux and sugar transport in adipose tissue and skeletal muscle. Biochim Biophys Acta 646: 261-267, 1983
13. Tamura S, Brown TA, Dubler RE, Larner J: Insulin-like effect of vanadate on adipocyte glycogen synthase and on phosphorylation of 95000 dalton subunit of insulin receptor. Biochem Biophys Res Commun 113: 80-86, 1983
14. Strout HV, Vicario PP, Saperstein R, Slater EE: The insulin-like effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragm in vivo. Endocrinology 124: 1918-1924, 1989
15. Meyerovitch J, Frafel Z, Sack J, Schechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozocin-treated rats. J Biol Chem 262: 6658-6662, 1987
16. Clark AS, Pagan JM, Mitch WE: Selectivity of the insulin-like actions of vanadate on glucose and protein metabolism in skeletal muscle. Biochem J 232: 273-276, 1985
17. Curran GL: Effect of certain transition group elements on hepatic synthesis of cholesterol in the rat. J Biol Chem 210: 765-770, 1954
18. Snyder F, Cornatzer WE: Vanadium inhibition of phospholipid synthesis and sulphydryl activity in rat liver. Nature 182: 462, 1958
19. Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474-1477, 1985
20. Brichard SM, Okitolonda W, Henquin JC: Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123: 2048-2053, 1988
21. Brichard SM, Assimacopoulous-Jeannet F, Jeanerenaud B: Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant falfa rats without modifying glucose transporter expression. Endocrinology 131: 311-317, 1992
22. Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH: Oral vanadyl sulfate in the treatment of diabetis mellitus in rats. Am J Physiol 257: H904-911, 1989
23. Ramanadham S, Brownsey RW, Cros GH, Mongold JJ, McNeill JH: Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment. Metabolism 38: 1022-1028, 1989
24. Sakurai H, Tsuchiya K, Nukatsuka M, Sofue M, Kawada J: Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats. J Endocrinol 126: 451-459, 1990
25. Goldfine AB, Folli F, Patti PE, Simonson DC, Kahn CR: Effects of vanadate on in vivo and in vitro insulin action in diabetes. Clin Res 42: 116A, 1994
26. Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L: Oral vanadyl sulphate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent Diabetes Mellitus. J Clin Invest 95: 2501-2509, 1995
27. Hackbarth I, Schmitz W, Scholz H, Erdmann E, Krawietz W, Philipp G: Positive inotropism of vanadate in cat papillary muscle. Nature (London) 275: 67-67, 1978
28. Grupp G, Grupp I, Johnson CL, Wallick ET, Schwartz A: Effects of vanadate on cardiac contraction and adenylate cyclase. Biochim Biophys Res Commun 88: 440-447, 1979
29. Borchard O, Fox AAL, Greeff KJ, Schlieper P: Negative and positive inotropic action of vanadate on atrial and ventricular myocardium. Nature (London) 279: 339-341, 1979
30. Cantley Jr LC, Cantley LG, Josephson L: A characterization of vanadate interaction with the (Na,K)-ATPase. Mechanistic and regulatory implications. J Biol Chem 253: 7361-7368, 1978
31. Schwabe L, Prichstein C, Hannemann H, Sichtig E: Activation of adenyl cyclase by vanadate. Nature 273: 141-145, 1980
32. +)-ATPase and on the force of contraction in guinea-pig hearts. Life Sci 25: 1803-1812, 1979
33. 2+-ATPase. Fed Proc 39: 979, 1980
34. 2+-ATPase of sarcoplasmic reticulum from pig heart. Basic Res Cardiol 75: 452-454, 1980
35. Takeda K, Temma K, Akera T: Inotropic Effects of vanadate in isolated rat and guinea pig heart under conditions which modify calcium pools involved in contractile activation. J Pharmacol Exp Ther 222: 132-139, 1982
36. Shah KR, Matsubara T, Foerster DR, Xu Y-J, Dhalla NS : Mechanisms of inotropic responses of the isolated rat hearts to vanadate. Int J Cardiol 52: 101-113, 1995
37. Paulson DJ, Kopp SJ, Tow JP, Peace DJ: Effects of vanadate on in vivo myocardial reactivity to norepinephrine in diabetic rats. J Pharmacol Exp Ther 240: 529-540, 1986
38. Sechi R, Repp H, Naimark BJ, Barwinsky J, Beamish RE, Dhalla NS: Characterization and mechanisms of tachyphylaxis of cardiac contractile response to insulin. Int J Cardiol 38: 119-130, 1993
39. + shift reagent for perfused rat hearts. Magn Reson Med 15: 25-32, 1990
40. Malloy CR, Buster DC, Castro MMCA, Geraldes CFGC, Jeffrey FMH, Sherry AD: Influence of global ischemia on intracellular sodium with perfused rat hearts studied in vivo by NMR. Magn Reson Med 15: 33-44, 1990
41. Butwell NB, Ramasamy R, Lazar I, Sherry AD, Malloy CR: Effect of lidocaine on contracture, intracellular sodium and pH in ischemic rat hearts. Am J Physiol 264: H1958-1962, 1992
42. Bergmeyer HU: Methods in Enzymatic Analysis. Academic Press, New York. pp 1464-1468, 1963
43. Roe JH, Dailey RE: Determination of glycogen with the anthrone reagent. Anal Biochem 15: 245-250, 1966
44. +)-ATPase activity. J Lab Clin Med 93: 790-796, 1979
45. Macara IG, Kustin K, Cantley LC: Glutathione reduces cytoplasmic vanadate. Mechanism and physiological implications. Biochim Biophys Acta 629: 95-106, 198?
46. Cantley Jr LC, Fergusson JH, Kustin K: Norepinephrine complexes and reduces vanadium(V) to reverse vanadate inhibition of the (Na,K)-ATPase. J Am Chem Soc 100: 5210-5212, 1978
47. Grantham JJ, Glynn IM: Renal Na,K-ATPase: determinants of inhibition by vanadium. Am J Physiol 236: F530-F535, 1979
48. Degani H, Gochin M, Karlish SJD, Schechter Y: Electron paramagnetic resonance studies and insulin-like effects of vanadium in rat adipocytes. Biochemistry 20: 5795-5799, 1981
49. Legum W: The mode of reduction of vanadate (+V) to oxovanadium (+IV) by glutathione and cysteine: Toxicology 42: 281-289, 1986
50. Nechay BR, Nanninga NB, Nechay PSE: Vanadyl (IV) and vanadate (V) binding to selected endogenous phosphate, carboxyl and amino ligands: calculations of cellular vanadium species distribution. Arch Biochem Biophys 251: 128-138, 1986
51. Liu H, McNeill JH: Effects of vanadium on the alterations of cardiac glycogen phosphorylase and phosphorylase kinase in streptozotocin-induced chronic diabetic rats. Can J Physiol Pharmacol 72: 1537-1543, 1994
52. Schaefer S, Carr LJ, Prussel E, Ramasamy R: Effects of glycogen depletion on ischemic injury in the isolated rat heart: insights into preconditioning. Am J Physiol 268: 11935-944, 1995
53. Anderson SE, Murphy E, Steenbergen C, London RE, Cala PM: Na-H exchange in myocardium: effects of hypoxia and acidification on Na and Ca. Am J Physiol 259: C940-948, 1990
54. + exchange. Am J Physiol 256: H2017-2026, 1993
55. Ramasamy R, Oates PJ, Schaefer S: Inhibition of aldose reductase protects diabetic hearts from ischemic injury. Diabetes (suppl 1); 192A, 1995
56. Gevers W: Generation of protons by metabolic processes in heart cells. J Mol Cell Cardiol 9: 867-874, 1977
57. Neely JR, Grotyohan LW: Role of glycolytic products in damage to ischemic myocardium. Circ Res 55: 816-824, 1984
58. Gross GJ, Auchampach JA: Blockade of ATP sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70: 223-233, 1992